Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Phenylephrine recalled?

Yes — there is an active recall. 17 ongoing FDA recalls mention Phenylephrine (292 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Phenylephrine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Phenylephrine recalls on record

none so far in 2026; 292 on record, newest first
Class II · Moderate risk

Phenylephrine HCI Injection

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Terminated Sterility / contamination Sandoz Inc NDC 66758-016-03 D-1514-2016
Class I · High risk

PHENYLephrine 1 mg/10 mL

Labeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10 mL (40 mcg/ml) on the light protective overwrap of each syringe.

Terminated Labeling / mix-up QuVa Pharma, Inc. D-1066-2016
Class II · Moderate risk

Tropicamide 1%/Phenylephrine 2.5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3214-07 D-0290-2016
Class II · Moderate risk

Tropicamide 0.5%/ Phenylephrine 5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3298-02 D-0289-2016
Class II · Moderate risk

Phenylephrine PF Sterile Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3272-03 D-0277-2016
Class II · Moderate risk

Phenylephrine PF

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3159-07 D-0276-2016
Class II · Moderate risk

Phenylephrine

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3289-05 D-0275-2016
Class II · Moderate risk

Phenylephrine 10% PF Ophthalmic Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3273-03 D-0274-2016
Class II · Moderate risk

Phenylephrine 1.5%/ Lidocaine 1%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3155-01 D-0273-2016
Class II · Moderate risk

PHENYLephrine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0087-2017
Class II · Moderate risk

PHENYLephrine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0086-2017